Doug Burkett, president of Champions Biotechnology, said: “Studies suggest that our Biomerk Tumorgrafts closely reflect human cancer biology and their response to drugs is more predictive of clinical
Bill Worthen, president and CEO of Alsius, said: “This is the sixth contract that we have been awarded by a major hospital group purchasing organization (GPO) in the
Under the agreement, Transition agreed to acquire a license to the technology for $2.5 million, which includes the extinguishment of $1.5 million of debt and an additional funding
The members of Balan’s engineering division support the internal R&D projects of St Jude Medical (SJM), allowing optimization of resources while providing cost effective expertise. Michael Pyszczek, vice
The trial will enroll approximately 120 patients. TopoTarget has a special protocol assessment agreement with the FDA where the design of the study has been agreed. Furthermore a
Under the terms of the agreement, CSL is responsible for the development of protein and antibody products resulting from this alliance. Financial terms of the agreement were not
BioFocus DPI will continue to provide biology, computational and medicinal chemistry services and will supply small molecule compounds for use in Amgen’s discovery programs. Under the terms of
The licensed patents result from the research of James Thompson of the University of Wisconsin Stem Cell and Regenerative Medicine Center and director of regenerative biology at the
By achieving statistical significance at the two highest doses of the three tested, the results essentially mirrored the findings of an earlier Phase II study also conducted in
The double-blind, randomized and repeated fixed-dose study compares MoxDuoIR’s efficacy and safety to corresponding doses of oxycodone and morphine in patients experiencing moderate to severe pain following a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.